BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 9811060)

  • 1. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
    Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
    Chizzolini C; Parel Y; Scheja A; Dayer JM
    Arthritis Res Ther; 2006; 8(1):R10. PubMed ID: 16356198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
    Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
    Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
    Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
    Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.
    Rosenbloom J; Saitta B; Gaidarova S; Sandorfi N; Rosenbloom JC; Abrams WR; Hamilton AD; Sebti SM; Kucich U; Jimenez SA
    Arthritis Rheum; 2000 Jul; 43(7):1624-32. PubMed ID: 10902768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
    Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
    Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
    Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
    J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.